The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
Rik Ossenkoppele(Malmö University), Gil D. Rabinovici(University of California, San Francisco), Annemieke J.M. Rozemüller(Amsterdam Neuroscience), Renaud La Joie(University of California, San Francisco), Joel H. Kramer(University of California, San Francisco), Philip Scheltens(Inserm), Wiesje M. van der Flier(Amsterdam Neuroscience), Eric J. Huang(University of California, San Francisco), Bruce L. Miller(Neurology, Inc), Bart N.M. van Berckel(Amsterdam Neuroscience), David C. Perry(Barrow Neurological Institute), William J. Jagust(Lawrence Berkeley National Laboratory), Frederik Barkhof(Netherlands Institute for Neuroscience), Howard J. Rosen, William W. Seeley(University of California, San Francisco), Brendan I. Cohn‐Sheehy(University of California, San Francisco), Annelies E. van der Vlies(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jacob W. Vogel(Malmö University), Nienke M.E. Scheltens(Amsterdam UMC Location Vrije Universiteit Amsterdam), Yolande A.L. Pijnenburg(Amsterdam Neuroscience), Lea T. Grinberg(Universidade de São Paulo)
Cited by 558
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k